logo

For the Inventor, By the Inventor

Tosu, Japan

Seiichi Shimizu

This inventor holds 7 USPTO granted patents. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1999-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seiichi Shimizu. Retrieved from https://idiyas.com/inventor/seiichi-shimizu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7

% Patents Active = 57.1

Average Co-Inventor Count = 5.2

ph-index = 4

Forward Citations = 46(Granted Patents)


Location History:

  • Otsu, JP (2002)
  • Tosu, JP (1999 - 2011)

Company Filing History:

goldMedal7 out of 846 
 
Otsuka Pharmaceutical Company, Limited
 patents

Years Active: 1999-2011

Loading Chart...
7 patents (USPTO):Explore Patents
1. 7939060 - Isoflavone-containing composition (2011-05-10),
2. 7345089 - Microbial method of making equol-containing composition and product made (2008-03-18),
3. 6884415 - Antioxidation food product, antioxidation preparation and antioxidation method (2005-04-26),
4. 6716424 - Streptococcus and isoflavone-containing composition (2004-04-06),
5. 6468556 - Liver fat accumulation inhibitory composition, food additive for liver fat accumulation, inhibition, and method of inhibiting liver fat accumulation (2002-10-22),
6. 6228358 - Method of producing fermented milk containing manganese and tea (2001-05-08),
7. 6004926 - Body fat percent-lowering, body composition-improving food composition (1999-12-21),

Title: Seiichi Shimizu - Innovator in Isoflavone Research

Introduction

Seiichi Shimizu is a notable inventor based in Tosu, Japan, recognized for his significant contributions to health-related innovations. With a total of seven patents to his name, Shimizu's work focuses primarily on addressing clinical syndromes, particularly those affecting middle-aged and elderly women.

Latest Patents

Among his latest inventions are two groundbreaking patents that offer promising solutions for health issues. The first is an isoflavone-containing composition, which includes a daidzein-containing substrate and a specific strain of micro-organism capable of metabolizing daidzein to equol. This invention serves as an effective measure for the prevention and alleviation of unidentified clinical syndromes, including menopausal syndrome, for which there has not been an effective means of treatment available until now. The second patent outlines a microbial method for creating an equol-containing composition and product, reinforcing the potential of these innovations in improving women's health.

Career Highlights

Seiichi Shimizu is affiliated with Otsuka Pharmaceutical Company, Limited, where he continues to apply his expertise in innovative research. His work at the company has been pivotal in advancing solutions that address various health concerns, thereby making a substantial impact on the pharmaceutical field.

Collaborations

Throughout his career, Shimizu has collaborated with esteemed colleagues, such as Shigeto Uchiyama and Kyosuke Masaki. These collaborations foster a shared vision of innovation, enriching the collective knowledge and developments in their field.

Conclusion

In summary, Seiichi Shimizu's inventive spirit and commitment to enhancing women's health through his patented innovations exemplify the role of dedicated inventors in fostering progress. His contributions at Otsuka Pharmaceutical Company, Limited, alongside his collaborative efforts with other professionals, establish him as a crucial figure in the realm of medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…